IL6 and Barrett esophagus: Kavanagh ME et al.242demonstrated Th2 phenotype in BE, characterized by elevated levels of IL‐4 producing CD4+ T‐cells and secreted levels of IL‐6, and immunocompromised T‐cells infiltrating EAC with low expression of CD45RO and CD69 that facilitate tumor progression and may represent a target for immune therapy.